Publication
Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey*
S.K. Mahil, M. Yates, S.M. Langan, Z.Z.N. Yiu, T. Tsakok, N. Dand, K.J. Mason, H. McAteer, F. Meynell, B. Coker, A. Vincent, D. Urmston, A. Vesty, J. Kelly, C. Lancelot, L. Moorhead, H. Bachelez, I.N. Bruce, F. Capon, C.R. Contreras, A.P. Cope, C. De La Cruz, P. Di Meglio, P. Gisondi, K. Hyrich, D. Jullien, J. Lambert, H. Marzo‐Ortega, I. McInnes, L. Naldi, S. Norton, L. Puig, R. Sengupta, P. Spuls, T. Torres, R.B. Warren, H. Waweru, J. Weinman, C.E.M. Griffiths, J.N. Barker, M.A. Brown, J.B. Galloway, C.H. Smith
British Journal of Dermatology, March 2021, Oxford University Press (OUP)
DOI: 10.1111/bjd.19755